The Evidence Speaks Series is a recurring feature highlighting the latest in CHÉOS research. This series features summaries of select publications and is designed to keep the media and the research community up-to-date with CHÉOS’ current research results in the health outcomes field. To ensure this research is quick and easy to share, we are now providing social cards that you are free to save and use as you see fit.
This edition includes research on the mental health outcomes of cancer patients, cardiovascular disease risk for people with latent TB, and a cost analysis of two treatments for prescription-type opioid use disorder.
Read More
This edition explores the use of telehealth for genetic testing in remote communities, the delivery of collaborative care in the treatment of eating disorders and treatment coverage for PTSD around the world.
Read More
This edition includes research on Mpox vaccine uptake among STI clinic clients, organized activities and the emotional wellbeing of children, and patient preferences for managing acute coronary syndrome
Read More
This edition includes results post-transanal endoscopic microsurgery, reflections from incomplete spinal cord injury patients, and triple mRNA vaccine dose efficacy
Read More
The first Evidence Speaks of 2023 features mask mandate effectiveness, client preferences for iOAT delivery, and patient-reported outcomes following hysterectomy
Read More
Featuring student experiences of suicidal ideation, multimorbidity among TB survivors in B.C., and sugary drinks and social jetlag in adolescents
Read More